United States Neuromodulation Devices Market Outlook to 2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4995
Buy Report

Published: December 15, 2019 Report Code: GDMECC4625DB-ST

Select Item

“What is covered in the report about the “United States Neuromodulation Devices Market”?
GlobalData’s “United States Neuromodulation Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS).

The United States Neuromodulation Devices Market report provides key information and data on
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Neuromodulation Devices market.
• Global corporate-level profiles of key companies operating within the United States Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

United States Neuromodulation Devices is segmented as follows:
• Deep Brain Stimulators (DBS)
• Gastric Electric Stimulators (GES)
• Leads
• Peripheral Nerve Stimulators (PNS)
• Sacral Nerve Stimulators (SNS)
• Spinal Cord Stimulators (SCS)
• Vagus Nerve Stimulators (VNS)

Key Reasons to Purchase
The United States Neuromodulation Devices Market report helps you to develop
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States Neuromodulation Devices Market Outlook to 2025” report
• Medtronic plc
• Abbott Laboratories

The GlobalData Differentiation
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 15,000+ primary interviews, conducted annually to ensure data and report quality
• 3,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 66.956+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 825+ companies’ revenue splits and market shares
• 2,000+ quarterly and annual medical equipment company financials
• 1,100+ medical equipment company SWOTs
• 26,400+ pipeline product profiles
• 52,400+ marketed product profiles
• 44,600+ clinical trials
• 52,400+ trial investigators
• 7,900+ reports on companies with products in development
• 42,000+ deals in the medical equipment industry
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx

Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

NA

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 8

1.2 List of Figures 8

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Neuromodulation Devices Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 10

3 Neuromodulation Devices Market, United States 11

3.1 Neuromodulation Devices Market, United States, Revenue ($m), 2015-2025 11

3.2 Neuromodulation Devices Market, United States, Volume (Units), 2015-2025 14

3.3 Neuromodulation Devices Market, United States, Average Price ($), 2015-2025 17

3.4 Neuromodulation Devices Market, United States, Distribution Share by Revenue ($m), 2018 19

3.5 Neuromodulation Devices Market, United States, Company Share by Revenue ($m), 2018 20

4 Overview of Key Companies in United States, Neuromodulation Devices Market 22

4.1 Medtronic Plc 22

4.1.1 Company Overview 22

4.2 Abbott Laboratories 22

4.2.1 Company Overview 22

4.3 Boston Scientific Corp 22

4.3.1 Company Overview 22

4.4 Nevro Corp 22

4.4.1 Company Overview 22

4.5 LivaNova PLC 23

4.5.1 Company Overview 23

4.6 Nuvectra Corp 23

4.6.1 Company Overview 23

5 Neuromodulation Devices Market Pipeline Products 24

6 Financial Deals Landscape 28

6.1 Acquisition 28

6.1.1 Smith & Nephew May Acquire NuVasive 28

6.1.2 Daan Dohmen to Acquire OMRON Healthcare 29

6.2 Debt Offerings 30

6.2.1 Boston Scientific Raises USD999.2 Million in Public Offering of

0.625% Notes Due 2027 30

6.2.2 Boston Scientific Raises USD1 Billion in Public Offering of

4.700% Notes Due 2049 32

6.2.3 Boston Scientific Raises USD750 Million in Public Offering of

4.550% Notes Due 2039 34

6.2.4 Boston Scientific Raises USD850 Million in Public Offering of

4.000% Notes Due 2029 36

6.2.5 Boston Scientific Raises USD850 Million in Public Offering of

3.450% Notes Due 2024 38

6.2.6 Boston Scientific Raises USD850 Million in Public Offering of

3.750% Notes Due 2026 40

6.3 Equity Offerings 42

6.3.1 Neuronetics Plans to Raise up to USD125 Million in Public Offering of Securities 42

6.3.2 Neuronetics Plans to Raise Funds through Public Offering of Shares 43

6.3.3 ElectroCore Plans to Raise up to USD50 Million in Public Offering of Securities 44

6.3.4 MRI Interventions Raises USD7.5 Million in Private Placement of Shares 45

6.3.5 Neurometrix Plans to Raise up to USD25 Million in Public Offering of Securities 47

6.3.6 Inspire Medical Prices Public Offering of Shares for USD100 Million 48

6.4 Partnerships 50

6.4.1 Cala Health Enters into Licensing Agreement with Partners Healthcare 50

6.5 Private Equity 51

6.5.1 New Heritage Capital Invests in Rhythmlink International 51

6.6 Venture Financing 52

6.6.1 StimAire Raises Funds through Series A Financing 52

6.6.2 ShiraTronics Raises USD33 Million in Series A Financing 53

6.6.3 Neuros Medical Raises USD2.4 Million in Venture Financing 55

6.6.4 Deep Brain Innovations Raises USD0.39 Million in Venture Financing 56

6.6.5 Cala Health Raises USD50 Million in Series C Financing 57

6.6.6 SPR Therapeutics Raises USD8 Million in Series C-1 Financing 60

6.6.7 SpineX Raises Funds through Seed Financing 61

6.6.8 EndoStim Raises USD2.8 Million in Venture Financing 62

6.6.9 BioWave Raises USD1 Million in Venture Financing 63

7 Recent Developments 64

7.1 Corporate Communications 64

7.1.1 Nov 14, 2019: Zynex ranked 18th in revenue growth among medical device companies 64

7.1.2 Nov 01, 2019: Neuronetics announces appointment of Sheryl Conley to its board of directors 64

7.1.3 Sep 30, 2019: electroCore appoints Medical Technology Veteran Daniel S. Goldberger as Chief Executive Officer 64

7.1.4 Sep 19, 2019: BrainsWay announces further leadership transition to U.S. 65

7.1.5 Sep 10, 2019: SetPoint Medical appoints Anna Gawlicka as VP of Clinical Affairs 65

7.1.6 Aug 28, 2019: Dynatronics promotes Brian Baker to Chief Executive Officer 66

7.1.7 Aug 21, 2019: NuVasive: Departure of directors or certain officers 66

7.1.8 Aug 21, 2019: Avanos Medical: Changes in senior management 67

7.1.9 Aug 12, 2019: GSK announces leadership changes in the US 67

7.1.10 Aug 06, 2019: Healthcare Veteran Kristine Johnson to join MRI Interventions' board of directors 67

7.1.11 Jul 31, 2019: NeuroPace appoints Mark Saxton as vice president of sales 68

7.1.12 Jul 25, 2019: Inspire Medical Systems announces changes to its board of directors 68

7.1.13 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 69

7.1.14 Jul 23, 2019: Zynex recognized as the fastest growing public company in Colorado based on net income 69

7.1.15 Jul 22, 2019: Zynex expands executive team, appoints Joseph Papandrea chief operating officer 69

7.1.16 Jul 17, 2019: Stimwave appoints Regina E. Groves and Marc A. Loev, M.D., to Board of Directors and James M. Rallo as Chief Financial Officer 70

7.1.17 Jul 03, 2019: Neuronetics appoints Stephen Furlong as Chief Financial Officer 71

7.1.18 Jun 25, 2019: Nevro announces executive appointments 71

7.1.19 Jun 10, 2019: electroCore announces Frank R. Amato to step down as chief executive officer 72

7.1.20 May 20, 2019: Nevro appoints D. Keith Grossman Chairman of the Board; Michael DeMane as Lead Director 72

7.1.21 May 20, 2019: Dymedix Diagnostics hires new Vice President of sales and business development 72

7.1.22 Apr 05, 2019: Professor Linda Carpenter joins Nexstim's Scientific Advisory Board 72

7.1.23 Mar 29, 2019: PolarityTE announces Richard Hague, formerly from Sanofi, Genzyme and recently Anika Therapeutics as Chief Operating Officer 73

7.1.24 Mar 19, 2019: Nevro announces new CEO, board appointments and agreement with Broadfin Capital 74

7.1.25 Mar 04, 2019: California Life Sciences Association (CLSA) adds GlaxoSmithKline and Blade Therapeutics to Board 74

7.1.26 Feb 28, 2019: Zynex names new Vice President of Sales and Marketing 75

7.1.27 Feb 26, 2019: SpineX appoints Scientific Advisory Board to guide development of non-invasive medical devices for neuromodulation of the spine 75

7.1.28 Feb 21, 2019: Nihon Kohden appoints new CEO of North American operations 77

7.1.29 Feb 21, 2019: Stimwave named to fast company’s list of 2019 world’s most innovative companies 77

7.1.30 Feb 15, 2019: Neuronetics announces appointment of Dr. Cheryl R. Blanchard to its Board of Directors 78

7.1.31 Feb 12, 2019: Sanofi names Ameet Nathwani as chief digital officer 79

7.1.32 Jan 03, 2019: NuVasive CEO J. Christopher Barry announces new organizational structure and Leadership Team 79

7.1.33 Dec 17, 2018: Avanos Medical names David Ball as Senior Vice President, Global Supply Chain & Procurement 80

7.1.34 Dec 10, 2018: Medtronic named one of America's Best Corporate Citizens in 2018 by Forbes Magazine 80

7.1.35 Dec 04, 2018: SANUWAVE Health: Departure of Directors or Certain Officers; Election of Directors; appointment of certain officers; compensatory arrangements of certain officers 81

7.2 Financial Announcements 81

7.2.1 Nov 15, 2019: SANUWAVE health reports third quarter 2019 financial results 81

7.2.2 Nov 13, 2019: electroCore announces third quarter 2019 financial results 83

7.2.3 Nov 12, 2019: Helius Medical Technologies reports third quarter 2019 financial results and provides business 84

7.2.4 Nov 12, 2019: MRI Interventions reports 62% increase in 2019 third quarter revenue 86

7.2.5 Nov 12, 2019: Dynatronics reports first quarter results for fiscal 2020 87

7.2.6 Nov 07, 2019: Salimetrics releases new Salivary Osteocalcin Test to support interdisciplinary research 88

7.2.7 Nov 07, 2019: Hanger reports third quarter 2019 financial results 90

7.2.8 Nov 06, 2019: Nevro reports third quarter 2019 financial results 91

7.2.9 Nov 05, 2019: Avanos Medical announces third quarter 2019 results, completes acquisition of Endoclear 92

7.2.10 Nov 05, 2019: Neuronetics reports third quarter 2019 financial and operating results 94

7.2.11 Nov 05, 2019: Inspire Medical Systems, announces third quarter 2019 financial results and increases 2019 outlook 95

7.2.12 Oct 30, 2019: NuVasive announces third quarter 2019 financial results 96

7.2.13 Oct 29, 2019: Zynex announces 2019 third quarter financial results 97

7.2.14 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 98

7.2.15 Oct 17, 2019: NeuroMetrix reports Q3 2019 financial results 99

7.2.16 Sep 25, 2019: Dynatronics reports fourth quarter and full year results for fiscal 2019 100

7.2.17 Aug 15, 2019: SANUWAVE Health reports second quarter 2019 financial results 100

7.2.18 Aug 13, 2019: electroCore announces second quarter 2019 financial results 102

7.2.19 Aug 08, 2019: Nevro reports second quarter 2019 financial results 103

7.2.20 Aug 08, 2019: Helius Medical Technologies Reports Second Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook 104

7.2.21 Aug 07, 2019: Hanger reports second quarter 2019 financial results 106

7.2.22 Aug 06, 2019: Avanos Medical announces second quarter 2019 results 108

7.2.23 Aug 06, 2019: Neuronetics reports second quarter 2019 financial and operating results 109

7.2.24 Aug 06, 2019: Inspire Medical Systems announces second quarter 2019 financial results and increases 2019 outlook 110

7.2.25 Aug 06, 2019: MRI Interventions reports 58% increase in 2019 second quarter revenue 111

7.2.26 Aug 01, 2019: Integer Holdings reports second quarter 2019 results 112

7.2.27 Jul 31, 2019: Zynex announces 2019 second quarter earnings 112

7.2.28 Jul 30, 2019: NuVasive announces second quarter 2019 financial results 113

7.2.29 Jul 24, 2019: Boston Scientific announces results for second quarter 2019 114

7.2.30 Jul 18, 2019: NeuroMetrix reports Q2 2019 financial results 115

7.2.31 Jun 17, 2019: Dyne Therapeutics announces support for END-DM1 natural history study of patients with Myotonic Dystrophy Type 1 (DM1) 116

7.2.32 May 21, 2019: Sanuwave Health reports first quarter 2019 financial results 117

7.2.33 May 14, 2019: electroCore reports first quarter 2019 financial results 119

7.2.34 May 14, 2019: Dynatronics reports financial results for third fiscal quarter 2019 119

7.2.35 May 09, 2019: Nevro reports first quarter 2019 financial results 120

7.2.36 May 09, 2019: Helius Medical Technologies reports first quarter 2019 financial results and provides business update; reaffirms full year 2019 outlook 121

7.2.37 May 08, 2019: Hanger announces financial results for the first quarter of 2019 122

7.2.38 May 07, 2019: Avanos Medical announces first quarter 2019 results 123

7.2.39 May 07, 2019: Neuronetics announces first quarter 2019 financial results 125

7.2.40 May 07, 2019: Inspire Medical Systems announces first quarter 2019 financial results and increases 2019 outlook 125

7.2.41 May 02, 2019: Integer Holdings reports first quarter 2019 results 126

7.2.42 May 01, 2019: NuVasive announces first quarter 2019 financial results 127

7.2.43 Apr 30, 2019: Zynex Announces 2019 First Quarter Earnings 128

7.2.44 Apr 30, 2019: MRI Interventions Reports 52% Increase in First Quarter Revenue 129

7.2.45 Apr 25, 2019: Neurometrix reports Q1 2019 financial results 130

7.2.46 Apr 24, 2019: Boston Scientific announces results for first quarter 2019 131

7.2.47 Apr 18, 2019: Mainstay Medical provides company update and publishes 2018 full year results 132

7.2.48 Mar 29, 2019: SANUWAVE Health reports record 2018 financial results 133

7.2.49 Mar 29, 2019: SANUWAVE Health reports record 2018 financial results 135

7.2.50 Mar 27, 2019: electroCore announces fourth quarter and full year 2018 financial results 136

7.2.51 Mar 14, 2019: Helius Medical Technologies reports fourth quarter and full year 2018 financial results and introduces full year 2019 outlook 137

7.2.52 Mar 14, 2019: Hanger reports fourth quarter 2018 results and provides 2019 outlook 139

7.2.53 Mar 11, 2019: MRI Interventions reports 36% increase in fourth quarter revenue and record quarterly clearpoint cases 141

7.2.54 Mar 05, 2019: Neuronetics reports fourth quarter and full year 2018 financial and operating results 143

7.2.55 Mar 05, 2019: Neuronetics announces fourth quarter and full year 2018 financial and operating results 144

7.2.56 Feb 26, 2019: Avanos Medical announces fourth quarter and full-year 2018 results, provides 2019 outlook 146

7.2.57 Feb 26, 2019: Inspire Medical Systems announces fourth quarter and full year 2018 financial results 148

7.2.58 Feb 21, 2019: Nevro reports fourth quarter and full year 2018 financial results 149

7.2.59 Feb 21, 2019: Integer Holdings reports results for fourth quarter and full year 2018 150

7.2.60 Feb 20, 2019: NuVasive reports fourth quarter and full year 2018 financial results 151

7.2.61 Feb 13, 2019: Dynatronics Announces Financial Results for Second Fiscal Quarter 2019 152

7.2.62 Feb 06, 2019: Boston Scientific announces results for fourth quarter and full year 2018 152

7.2.63 Jan 24, 2019: NeuroMetrix reports Q4 and full year 2018 financial results 154

7.2.64 Jan 14, 2019: Carl Zeiss Meditec achieves strong revenue and EBIT growth in first three months 2018/19 155

7.2.65 Jan 08, 2019: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2018 155

7.2.66 Jan 07, 2019: Neuronetics announces preliminary fourth quarter and full year revenue 155

7.2.67 Jan 07, 2019: NuVasive Announces Preliminary Unaudited Fourth Quarter And Full Year 2018 Revenue Results 156

7.2.68 Jan 07, 2019: Nevro announces preliminary unaudited fourth quarter and full year 2018 revenue 157

7.3 Government and Public Interest 157

7.3.1 Apr 08, 2019: Inspire Medical Systems announces three new positive coverage policies issued by Blue Cross Blue Shield Plans 157

7.3.2 Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare 157

7.4 Legal And Regulatory 158

7.4.1 Oct 30, 2019: SANUWAVE successfully completes extensive round of quality system and technical file audits 158

7.4.2 Aug 27, 2019: Alphatec announces favorable judgment in NuVasive v. Miles lawsuit 159

7.4.3 Jul 16, 2019: Swiss agree to extradite Chinese researcher in US corporate espionage case 160

7.4.4 May 04, 2019: Vectura wins US GSK Patent Litigation and awarded $89.7Million in damages by Trial Jury 160

7.4.5 Feb 21, 2019: Stimwave addresses patent infringement lawsuit brought by Nevro 161

7.4.6 Feb 21, 2019: Fisher & Paykel Healthcare confirms no material impact on earnings guidance 161

7.4.7 Feb 15, 2019: BRAVO BIDCO: Update on the proposed acquisition of BTG 161

7.4.8 Jan 22, 2019: Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences 162

7.4.9 Jan 15, 2019: Boston Scientific, Edwards Lifesciences agree to global litigation settlement 162

7.4.10 Dec 18, 2018: Sanofi to transfer U.S. stock exchange listing to Nasdaq 162

7.5 Other Significant Developments 162

7.5.1 Nov 12, 2019: Integer announces commitments to reprice and extend maturity of its revolving credit facility and term Loan A; launches term Loan B repricing 162

7.5.2 Oct 22, 2019: EPFL spin-off GTX medical moves into the US market 162

7.5.3 Oct 08, 2019: University of Pittsburgh: Improving neural implants 163

7.5.4 Oct 07, 2019: UI pain researchers are part of major national effort to curb opioid use 164

7.5.5 Sep 10, 2019: Kazan Federal University and Mayo Clinic implement unique rehabilitation technology to treat spinal cord injuries 164

7.5.6 Aug 28, 2019: Fisher & Paykel Healthcare upgrades Guidance 165

7.5.7 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica 166

7.5.8 Jul 11, 2019: Joe Montana professional Football Hall of Famer joins Stimwave Technologies as official spokesperson 166

7.5.9 Jun 27, 2019: NeuroMetrix provides strategic update 167

7.5.10 May 30, 2019: Nuvasive SpineTRACK Registry successfully meets 2018 medicare reporting requirements for merit-based incentive payments system 167

7.5.11 May 15, 2019: Abbott partners NIH to advance neurostimulation therapies 168

7.5.12 May 06, 2019: Inspire Medical Systems announces additional

11.2 million covered lives with new blue cross blue shield coverage policies 168

7.5.13 Apr 10, 2019: SANUWAVE provides an update on international registrations received, attendance at Trade Shows and ISO Certification 169

7.5.14 Apr 02, 2019: Greenbrook TMS selected by Kaiser Permanente as provider of TMS therapy services in the Mid-Atlantic States 170

7.5.15 Mar 19, 2019: Zynex reactivates medicare provider number in effort to accelerate growth 170

7.5.16 Mar 11, 2019: New genetic data from Regeneron and GSK on 50,000 UK Biobank participants made available to global health research community 170

7.5.17 Mar 04, 2019: Inspire Medical Systems announces five new positive coverage policies issued by Blue Cross Blue Shield Plans 171

7.5.18 Jan 23, 2019: Sanofi joins Startup Creasphere – Munich's first digital health focused innovation program 172

7.5.19 Jan 21, 2019: FocusCura subsidiary Luscii will continue as independent company with partner OMRON Healthcare to accelerate their international expansion 173

7.5.20 Jan 07, 2019: Inspire Medical Systems announces issuance of positive assessment for inspire therapy by Blue Cross Blue Shield Association''s Evidence Street 173

7.6 Product News 174

7.6.1 Aug 16, 2019: RPW Technology announces the launch Of Liftid Neurostimulation 174

7.6.2 Aug 14, 2019: Dynatronics to attend The National by FCA 2019 174

7.6.3 Aug 08, 2019: NuVasive presents long-term strategy and financial outlook at 2019 investor day 174

7.6.4 May 28, 2019: Brain stimulation may improve sight recovery after stroke 175

7.6.5 Apr 24, 2019: Dynatronics to attend the IMCO 2019 National Convention 175

7.6.6 Apr 04, 2019: Dynatronics to attend the NDC Exhibition 2019 176

7.6.7 Mar 07, 2019: Dynatronics to attend the American Academy of Orthopaedic Surgeons 2019 Annual Meeting 176

7.7 Strategy And Business Planning 176

7.7.1 Oct 15, 2019: Subtle Medical receives FDA 510(k) clearance for AI-powered SubtleMR 176

7.7.2 Oct 15, 2019: Sanofi opens digital manufacturing facility in the US 177

7.7.3 Jun 24, 2019: Boston Scientific Galway expands in to new facility 178

7.7.4 May 21, 2019: Verily forms strategic alliances with Novartis, Otsuka, Pfizer and Sanofi to transform clinical research 178

7.7.5 May 09, 2019: Greenbrook TMS announces expansion into Michigan 180

7.7.6 Apr 23, 2019: SANUWAVE Health Enters the Carolinas, Hires Key Representative and Will Participate in the Modern Wound Care Management Conference 180

7.7.7 Mar 12, 2019: Zynex expands corporate headquarters to accommodate growth 181

8 Appendix 182

8.1 Research Methodology 183

8.1.1 Coverage 183

8.1.2 Secondary Research 183

8.1.3 Primary Research 184

8.1.4 Market Modeling and Forecasting 185

8.1.5 Company Share Analysis 186

8.1.6 Distribution Share Analysis 187

8.1.7 Benchmarking 187

8.2 GlobalData Consulting 187

8.3 Contact Us 188

8.4 Disclaimer 188

Table

1.1 List of Tables

Table 1: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 12

Table 2: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 13

Table 3: Neuromodulation Devices Market, United States, Volume (Units), 2015-2020 15

Table 4: Neuromodulation Devices Market, United States, Volume (Units), 2021-2025 16

Table 5: Neuromodulation Devices Market, United States, Average Price ($), 2015-2020 17

Table 6: Neuromodulation Devices Market, United States, Average Price ($), 2021-2025 18

Table 7: Neuromodulation Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 19

Table 8: Neuromodulation Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2018 21

Table 9: Neuromodulation Devices Market Pipeline Products 24

Table 10: Smith & Nephew May Acquire NuVasive 28

Table 11: Daan Dohmen to Acquire OMRON Healthcare 29

Table 12: Boston Scientific Raises USD999.2 Million in Public Offering of 0.625% Notes Due 2027 30

Table 13: Boston Scientific Raises USD1 Billion in Public Offering of 4.700% Notes Due 2049 32

Table 14: Boston Scientific Raises USD750 Million in Public Offering of 4.550% Notes Due 2039 34

Table 15: Boston Scientific Raises USD850 Million in Public Offering of 4.000% Notes Due 2029 36

Table 16: Boston Scientific Raises USD850 Million in Public Offering of 3.450% Notes Due 2024 38

Table 17: Boston Scientific Raises USD850 Million in Public Offering of 3.750% Notes Due 2026 40

Table 18: Neuronetics Plans to Raise up to USD125 Million in Public Offering of Securities 42

Table 19: Neuronetics Plans to Raise Funds through Public Offering of Shares 43

Table 20: ElectroCore Plans to Raise up to USD50 Million in Public Offering of Securities 44

Table 21: MRI Interventions Raises USD7.5 Million in Private Placement of Shares 45

Table 22: Neurometrix Plans to Raise up to USD25 Million in Public Offering of Securities 47

Table 23: Inspire Medical Prices Public Offering of Shares for USD100 Million 48

Table 24: Cala Health Enters into Licensing Agreement with Partners Healthcare 50

Table 25: New Heritage Capital Invests in Rhythmlink International 51

Table 26: StimAire Raises Funds through Series A Financing 52

Table 27: ShiraTronics Raises USD33 Million in Series A Financing 53

Table 28: Neuros Medical Raises USD2.4 Million in Venture Financing 55

Table 29: Deep Brain Innovations Raises USD0.39 Million in Venture Financing 56

Table 30: Cala Health Raises USD50 Million in Series C Financing 57

Table 31: SPR Therapeutics Raises USD8 Million in Series C-1 Financing 60

Table 32: SpineX Raises Funds through Seed Financing 61

Table 33: EndoStim Raises USD2.8 Million in Venture Financing 62

Table 34: BioWave Raises USD1 Million in Venture Financing 63

Table 40: Total Number of Primary Research Participants, Neurology Devices Market, by Country 185

Figures

1.2 List of Figures

Figure 1: Neuromodulation Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 11

Figure 2: Neuromodulation Devices Market, United States, Volume (Units), 2015-2025 14

Figure 3: Neuromodulation Devices Market, United States, Company Share (%) 2018 20

Frequently asked questions

United States Neuromodulation Devices Market Outlook to 2025 standard reports
Currency USD
$4,995

Can be used by individual purchaser only

Most Popular
$9,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Neurology Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Neuromodulation Devices Market Outlook to 2025 in real time.

  • Access a live United States Neuromodulation Devices Market Outlook to 2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more